HSP90AA1 and glioblastoma: However, combining Hsp90 inhibitors with standard GBM therapies like TMZ or radiation shows promise as a therapeutic strategy, with encouraging outcomes in in vitro/in vivo studies, suggesting further studies in various clinical settings.